Amazon investors reject New York retirement fund’s call for a racial-equity audit, 10 other shareholder proposals

[ad_1] Amazon.com Inc. investors rejected all 11 shareholder proposals at the company’s annual meeting this week, but vote totals released

Read more

Nissan to invest $1.8 billion in new electric-vehicle battery plants with Chinese partner, according to report

[ad_1] Nissan will invest more than 200 billion yen ($1.8 billion) in building new electric-vehicle battery plants in the U.K.

Read more

Opinion: The pandemic PC boom is still happening, but twin dangers loom

[ad_1] After more than a year into COVID-19 pandemic, people are still buying personal computers in massive numbers, but PC

Read more

The FDA authorized the third monoclonal antibody treatment. Here’s why Vir and GSK say the U.S. still needs COVID-19 therapies

[ad_1] There are now three antibody-based treatments available in the U.S. to treat adults and teens with mild or moderate

Read more

‘An organic, social-media phenomenon’: TikTok is driving a surge in demand for young-adult fiction novels

[ad_1] Some people go on TikTok to see funny clips of dogs popping out of watermelons, learn new dances or

Read more

Airbus ramps up A320 jet production as aerospace giant signals recovery

[ad_1] Airbus on Thursday outlined plans to increase production of its popular single-aisle passenger jets, signaling recovery for the aviation

Read more

Snowflake stock drops 3% after losses double

[ad_1] Snowflake Inc. shares melted a bit in the extended session Wednesday, after the software company revealed that losses are

Read more

Facebook set for antitrust investigation over Marketplace platform: report

[ad_1] The European Union is set to open a formal antitrust probe into Facebook as soon as within the next

Read more

‘Irresponsible’ bitcoin ads banned for being misleading

[ad_1] An advertising campaign telling people that it was “time to buy” bitcoin has been banned for being misleading, after

Read more

AstraZeneca’s $39 billion takeover of U.S.-based Alexion Pharmaceuticals examined by U.K. regulator

[ad_1] The U.K.’s Competition and Markets Authority said on Tuesday it was opening a consultation on the $39 billion planned

Read more